10-K Decoder · All companies

Acumen Pharmaceuticals, Inc.

ABOS · FY2025 · Fiscal year ended Dec 31, 2025 · 10-K filed Mar 2026

Open the dashboardInfographicSummary

FY2025 key figures

$FY2025FY2024Change
Revenue$0K$0K
Operating income−$124M−$114M−8.6%
Net income−$121M−$102M−18.6%

Latest quarter: Q3 2026

Form 10-Q · Three months ended Sep 30, 2026 · filed Oct 26, 2026

$Q3 2026Year earlierChange
Revenue$0K$0K
Operating income−$25.8M−$26.5M+2.6%
Net income−$25.4M−$26.5M+4.2%

Q3 2026 dashboardQ3 2026 infographic

Questions

What was Acumen's revenue in FY2025?
$0K in FY2025 (Fiscal year ended Dec 31, 2025), no comparable figure vs $0K a year earlier, per its 10-K filed Mar 2026.
Was Acumen profitable in FY2025?
No: net income was −$121M and operating income −$124M in FY2025.
What was Acumen's revenue in Q3 2026?
$0K (n/a vs a year earlier), per its Form 10-Q filed Oct 26, 2026.